Experience Collaborative Biologics Discovery
Dotmatics offers an end-to-end, data-driven software platform that digitizes and automates biologics R&D lab functions, enabling over 2 million researchers to rapidly access, visualize, and analyze complex biologics data—such as antibody, CAR-T, and RNA therapeutics—while integrating with familiar tools like GraphPad Prism and SnapGene to improve decision-making and accelerate drug discovery.
Data-Driven Biologics Discovery
Get a demo of the first true end-to-end software solution for biologics R&D.
The Challenges
- 80% of scientists state workarounds are required to get data into meaningful outputs and this is negatively impacting their work.
- 2/3 of scientists report compromised decision making due to informatics challenges.
Our Solution
Dotmatics digitizes and automates lab functions so researchers can rapidly access and analyze high quality data for more effective and timely decision making. It is also the only platform that is designed to handle the wide variety of biologics research to support your current and future research needs.
What is Dotmatics?
The Dotmatics platform allows users to access, visualize, and quickly analyze their complex data in order to make better, data-driven decisions. With Dotmatics, researchers can keep up with the diversification of biologics by accelerating drug discovery and related research across multiple biological modalities including antibody, CAR-T, and RNA therapeutics.
Never Compromise – Use Software You Already Love
Dotmatics has created a different approach with an end-to-end ecosystem of best-in-breed software that you already know, including GraphPad Prism, SnapGene, Geneious Prime, Geneious Biologics, and others.
Join more than 2 million researchers using our scientific solutions to advance life-changing discoveries.
Get a Demo to Learn More
To speak with a Dotmatics expert, provide some information about your organization, and we’ll contact you about your needs.
Related
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
Scientific Workflow Software
Dotmatics is a global leader in R&D scientific software that digitizes and automates lab workflows to provide high-quality data access, supports multimodal drug discovery across biology and chemistry, integrates best-in-breed applications like GraphPad Prism and SnapGene, and addresses informatics challenges that compromise 80% of scientists' data outputs and 2/3 of their decision-making, enabling over 2 million researchers to accelerate life-changing discoveries.
Dotmatics Chemicals & Materials Science Software Demo
Dotmatics offers a comprehensive, end-to-end scientific software platform that digitizes and automates lab functions for chemicals and materials research, integrating best-in-class tools like GraphPad Prism and SnapGene to help over 2 million researchers overcome data challenges, improve decision-making, and accelerate R&D workflows.
Dotmatics Appoints Mike McKee as President and CEO
Dotmatics Ltd has appointed experienced technology CEO Mike McKee as its new President to accelerate the company's growth, scale its global team, double R&D investments, and lead integration efforts within Insightful Science's portfolio, succeeding founder Stephen Gallagher who will focus on strategic growth initiatives.
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
Our 11 Most-Read Blogs of 2023: AI, Biologics, ELNs, and More
Dotmatics' top blogs of 2023 highlight key scientific advancements including the convergence of small molecule and biologic drug development, the integration and comparison of LIMS and ELN systems for enhanced lab data management, and strategies to minimize human errors in biologics research through automation and calibration.